SUBSCRIBE: Print / Digital / eNewsletter
Rho kinase inhibitors—the newest drugs introduced for treating glaucoma—"get to the heart of the matter” by targeting specific glaucomatous abnormalities, such as trabecular meshwork outflow, said Yvonne Ou, MD.
By Dr Yasmine M. El Sayed
Bleb leaks are a complication of trabeculectomy that occur despite improved success rates with local application of mitomycin C. Neeru Gupta, MD, PhD, MBA, shared her useful and simple approach for dealing with bleb leaks.
A high number of corneal diseases only affect the inner layers of the cornea, that is, the Descemet membrane (DM) and endothelium.
From timolol to rho kinase inhibitors, glaucoma medications for primary open-angle glaucoma (POAG) have steadily progressed for decades.
Intravitreal injections used to treat a variety of ocular diseases may themselves contribute to progressive visual loss with chronic administration over years, according to researchers.
Genetic variants that are unrelated to the IOP are associated with a family history of glaucoma and play a role in the onset of primary open-angle glaucoma (POAG).
Daria Lemann-Blumenthal, CEO of BELKIN Laser Ltd, provides an update on how the company's operations have continued to progress amid the coronavirus pandemic.
This article was reviewed by Joseph F. Panarelli, MD
Ellie Chabi, MD, therapeutic area head for Glaucoma & Neuroprotection, lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, shares insight on the company's role in the panel discussion focusing on new
Victor Chan, MBA, MS, director of U.S.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
